AIM: To evaluate the long-term outcome of patients with Takotsubo syndrome (TTS) and severely reduced left ventricular ejection fraction (LVEF ≤ 35%) at presentation. METHODS AND RESULTS: The study population included 326 patients (mean age 69.5 ± 10.7 years, 28 male) with TTS enrolled in the Takotsubo Italian Network, divided into two groups according to LVEF (≤ 35%, n = 131; > 35%, n = 195), as assessed by transthoracic echocardiography at hospital admission. In-hospital events were recorded in both groups. At long-term follow-up (median 26.5 months, interquartile range 18-33), composite major adverse cardiac events (MACE: cardiac death, acute myocardial infarction, heart failure, and TTS recurrence) and rehospitalization were investigated. Compared to patients with LVEF > 35%, patients with LVEF ≤ 35% were older (71.2 ± 10.8 vs. 68.4 ± 10.6 years; P = 0.026) and experienced more frequently cardiogenic shock (16% vs. 4.6%; P < 0.001), acute heart failure (28.2% vs. 12.8%; P = 0.001), and intra-aortic balloon pump support (11.5% vs. 2.6%; P = 0.001) in the acute phase. At long-term follow-up, higher rates of composite MACE (25.2% vs. 10.8%; P = 0.001) and rehospitalization for cardiac causes (26% vs. 13.3%; P = 0.004) were observed in these patients. LVEF ≤ 35% at admission [hazard ratio (HR) 2.184, 95% confidence interval (CI) 1.231-3.872; P = 0.008] and age (HR 1.041, 95% CI 1.011-1.073; P = 0.006) were independent predictors of MACE. Patients with LVEF ≤ 35% also had a significant lower freedom from composite MACE during long-term follow-up (χ2 = 11.551, P = 0.001). CONCLUSION: Left ventricular ejection fraction ≤ 35% at presentation is a key parameter to identify TTS patients at higher risk not only in the acute phase but also at long-term follow-up.
AIM: To evaluate the long-term outcome of patients with Takotsubo syndrome (TTS) and severely reduced left ventricular ejection fraction (LVEF ≤ 35%) at presentation. METHODS AND RESULTS: The study population included 326 patients (mean age 69.5 ± 10.7 years, 28 male) with TTS enrolled in the Takotsubo Italian Network, divided into two groups according to LVEF (≤ 35%, n = 131; > 35%, n = 195), as assessed by transthoracic echocardiography at hospital admission. In-hospital events were recorded in both groups. At long-term follow-up (median 26.5 months, interquartile range 18-33), composite major adverse cardiac events (MACE: cardiac death, acute myocardial infarction, heart failure, and TTS recurrence) and rehospitalization were investigated. Compared to patients with LVEF > 35%, patients with LVEF ≤ 35% were older (71.2 ± 10.8 vs. 68.4 ± 10.6 years; P = 0.026) and experienced more frequently cardiogenic shock (16% vs. 4.6%; P < 0.001), acute heart failure (28.2% vs. 12.8%; P = 0.001), and intra-aortic balloon pump support (11.5% vs. 2.6%; P = 0.001) in the acute phase. At long-term follow-up, higher rates of composite MACE (25.2% vs. 10.8%; P = 0.001) and rehospitalization for cardiac causes (26% vs. 13.3%; P = 0.004) were observed in these patients. LVEF ≤ 35% at admission [hazard ratio (HR) 2.184, 95% confidence interval (CI) 1.231-3.872; P = 0.008] and age (HR 1.041, 95% CI 1.011-1.073; P = 0.006) were independent predictors of MACE. Patients with LVEF ≤ 35% also had a significant lower freedom from composite MACE during long-term follow-up (χ2 = 11.551, P = 0.001). CONCLUSION: Left ventricular ejection fraction ≤ 35% at presentation is a key parameter to identify TTS patients at higher risk not only in the acute phase but also at long-term follow-up.
Authors: Mohammad Abumayyaleh; Ibrahim El-Battrawy; Marvin Kummer; Thorsten Gietzen; Michael Behnes; Xiao-Bo Zhou; Siegfried Lang; Martin Borggrefe; Ibrahim Akin Journal: In Vivo Date: 2020 Nov-Dec Impact factor: 2.155
Authors: Kalliopi Keramida; Johannes Backs; Eduardo Bossone; Rodolfo Citro; Dana Dawson; Elmir Omerovic; Guido Parodi; Birke Schneider; Jelena R Ghadri; Linda W Van Laake; Alexander R Lyon Journal: ESC Heart Fail Date: 2020-01-29
Authors: Ken Kato; Victoria L Cammann; L Christian Napp; Konrad A Szawan; Jozef Micek; Sara Dreiding; Rena A Levinson; Vanya Petkova; Michael Würdinger; Alexandru Patrascu; Rafael Sumalinog; Sebastiano Gili; Christian F Clarenbach; Malcolm Kohler; Manfred Wischnewsky; Rodolfo Citro; Carmine Vecchione; Eduardo Bossone; Michael Neuhaus; Jennifer Franke; Benjamin Meder; Milosz Jaguszewski; Michel Noutsias; Maike Knorr; Susanne Heiner; Fabrizio D'Ascenzo; Wolfgang Dichtl; Christof Burgdorf; Behrouz Kherad; Carsten Tschöpe; Annahita Sarcon; Jerold Shinbane; Lawrence Rajan; Guido Michels; Roman Pfister; Alessandro Cuneo; Claudius Jacobshagen; Mahir Karakas; Wolfgang Koenig; Alexander Pott; Philippe Meyer; Marco Roffi; Adrian Banning; Mathias Wolfrum; Florim Cuculi; Richard Kobza; Thomas A Fischer; Tuija Vasankari; K E Juhani Airaksinen; Monika Budnik; Rafal Dworakowski; Philip MacCarthy; Christoph Kaiser; Stefan Osswald; Leonarda Galiuto; Christina Chan; Paul Bridgman; Daniel Beug; Clément Delmas; Olivier Lairez; Ekaterina Gilyarova; Alexandra Shilova; Mikhail Gilyarov; Ibrahim El-Battrawy; Ibrahim Akin; Martin Kozel; Petr Tousek; David E Winchester; Jan Galuszka; Christian Ukena; Gregor Poglajen; Pedro Carrilho-Ferreira; Christian Hauck; Carla Paolini; Claudio Bilato; Masanori Sano; Iwao Ishibashi; Masayuki Takahara; Toshiharu Himi; Yoshio Kobayashi; Abhiram Prasad; Charanjit S Rihal; Kan Liu; P Christian Schulze; Matteo Bianco; Lucas Jörg; Hans Rickli; Gonçalo Pestana; Thanh H Nguyen; Michael Böhm; Lars S Maier; Fausto J Pinto; Petr Widimský; Stephan B Felix; Grzegorz Opolski; Ruediger C Braun-Dullaeus; Wolfgang Rottbauer; Gerd Hasenfuß; Burkert M Pieske; Heribert Schunkert; Martin Borggrefe; Holger Thiele; Johann Bauersachs; Hugo A Katus; John D Horowitz; Carlo Di Mario; Thomas Münzel; Filippo Crea; Jeroen J Bax; Thomas F Lüscher; Frank Ruschitzka; Jelena R Ghadri; Christian Templin Journal: ESC Heart Fail Date: 2021-03-13
Authors: Alaa Alashi; Nicolas Isaza; Jackson Faulx; Zoran B Popovic; Venu Menon; Stephen G Ellis; Michael Faulx; Samir R Kapadia; Brian P Griffin; Milind Y Desai Journal: J Am Heart Assoc Date: 2020-08-05 Impact factor: 5.501